Appropriate intraprocedural initial heparin dosing in patients undergoing catheter ablation for atrial fibrillation receiving uninterrupted non-vitamin-K antagonist oral anticoagulant treatment

Table 3 Bleeding and thromboembolic complications

Complications (n)	NG110	NG120	NG130	WG	p
Thromboembolic complications (n)	0 (0)	0 (0)	0 (0)	0 (0)	N/A
Stroke/TIAs	0 (0)	0 (0)	0 (0)	0 (0)	N/A
DVT	0 (0)	0 (0)	0 (0)	0 (0)	N/A
PE	0 (0)	0 (0)	0 (0)	0 (0)	N/A
Bleeding complications (n)	1 (2%)	1 (2%)	2 (4%)	2 (5%)	0.849
Major bleeding	0 (0)	0 (0)	1 (2%)	0 (0)	1.000
Cardiac tamponade	0 (0)	0 (0)	0 (0)	0 (0)	N/A
Delayed cardiac tamponade	0 (0)	0 (0)	0 (0)	0 (0)	N/A
Retroperitoneal hemorrhage	0 (0)	0 (0)	0 (0)	0 (0)	N/A
Hemoglobin drop ≥ 4 g/dL	0 (0)	0 (0)	0 (0)	0 (0)	N/A
Blood transfusion required	0 (0)	0 (0)	1 (2%)	0 (0)	1.000
Minor bleeding	1 (2%)	1 (2%)	1 (2%)	2 (5%)	0.812
Pericardial effusion	0 (0)	0 (0)	0 (0)	1 (2.5%)	0.203
Inguinal hematoma	1 (2%)	1 (2%)	1 (2%)	1 (2.5%)	1.000
Hematuria	0 (0)	0 (0)	0 (0)	0 (0)	N/A
Bleeding/thromboembolic complications	1 (2%)	1 (2%)	2 (4%)	2 (5%)	0.849

TIAs transient ischemic attacks, DVT deep venous thrombosis, PE pulmonary embolism

ISSN: 1471-2261